ENDV logo

Endonovo Therapeutics Inc

ENDV

$0.00

- $0.00 (-25.00%) This month

Closed: 28 Feb 2024 21:00 US/Eastern

Key details

CEO

Alan Collier

Employees

5

Headquarters

Woodland Hills, US

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

About Endonovo Therapeutics Inc

endonovo therapeutics (otcqb: endv) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. endonovo's immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. endonovo's cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and time-varying electromagnetic fields (tvemf) for tissue engineering and cell therapies.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG